Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

China flag China · Delayed Price · Currency is CNY
4.190
+0.010 (0.24%)
Mar 10, 2026, 3:00 PM CST
0.24%
Market Cap 4.58B
Revenue (ttm) 2.87B
Net Income (ttm) 16.30M
Shares Out 1.09B
EPS (ttm) 0.01
PE Ratio 280.27
Forward PE n/a
Dividend 0.10 (2.34%)
Ex-Dividend Date Jun 12, 2025
Volume 7,299,077
Average Volume 8,511,889
Open 4.180
Previous Close 4.180
Day's Range 4.160 - 4.200
52-Week Range 3.630 - 4.790
Beta 0.22
RSI 49.37
Earnings Date Mar 28, 2026

About SHA:600488

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company’s primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation prepar... [Read more]

Sector Healthcare
Founded 1939
Employees 2,884
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600488
Full Company Profile

Financial Performance

In 2024, SHA:600488's revenue was 3.22 billion, a decrease of -15.00% compared to the previous year's 3.78 billion. Earnings were 133.45 million, an increase of 14.01%.

Financial Statements

News

There is no news available yet.